Cogent Biosciences, Inc. COGT Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Cogent Biosciences, Inc.’s reported figures.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s free cash flow?
- Cogent Biosciences, Inc. (COGT) reported free cash flow of -$87.33M in Q1 2026.
- How has Cogent Biosciences, Inc.'s free cash flow changed year-over-year?
- Cogent Biosciences, Inc.'s free cash flow decreased by 30.2% year-over-year, from -$67.06M to -$87.33M.
- What is the long-term trend for Cogent Biosciences, Inc.'s free cash flow?
- Over 3 years (2022 to 2025), Cogent Biosciences, Inc.'s free cash flow has grown at a 28.5% compound annual growth rate (CAGR), from -$125.5M to -$266M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.